MEDICOX Co., Ltd. (KOSDAQ:054180)
South Korea · Delayed Price · Currency is KRW 2,295.00
-270.00 (-10.53%)
At close: Jul 2, 2025, 3:30 PM KST
MEDICOX Revenue
MEDICOX had revenue of 6.82B KRW in the quarter ending March 31, 2025, a decrease of -8.66%. This brings the company's revenue in the last twelve months to 29.96B, up 3.15% year-over-year. In the year 2024, MEDICOX had annual revenue of 30.61B with 13.90% growth.
Revenue (ttm)
29.96B
Revenue Growth
+3.15%
P/S Ratio
0.42
Revenue / Employee
379.29M
Employees
79
Market Cap
12.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.61B | 3.74B | 13.90% |
| Dec 31, 2023 | 26.88B | 6.58B | 32.42% |
| Dec 31, 2022 | 20.30B | 2.85B | 16.32% |
| Dec 31, 2021 | 17.45B | 1.26B | 7.78% |
| Dec 31, 2020 | 16.19B | -5.91B | -26.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |